Trochlear Salvage Plating System
Skeletal Dynamics, Inc. · Decision date Oct 26, 2026
What did the FDA decide?
The FDA recorded a substantially equivalent (SESE) decision on 26 October 2026 for the Trochlear Salvage Plating System, submitted by Skeletal Dynamics, Inc. of Miami, Florida, under 510(k) number K261135. The device falls under the classification name Plate, Fixation, Bone, regulation number 888.3030, with primary product code HRS and subsequent product code OZI; the regulation medical specialty and review panel are both listed as Orthopedic. The application was received on 7 April 2026.
SESE in a 510(k) context denotes clearance to market, not premarket approval. The record identifies the submission as a Traditional 510(k) that was not reviewed by a third party, was not a combination product, and had no authorized predetermined change control plan. The public record does not describe the specific components, materials, or design changes supporting the equivalence determination, and no summary statement is included in the available data, so the technical basis for clearance remains unknown from this source.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Orthopedic
- Decision date
- Oct 26, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261135
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Skeletal Dynamics, Inc.
- Product code
- HRS
- Decision code
- SESE
- Decision date
- Oct 26, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Plate, Fixation, Bone.
- Applicant
- Skeletal Dynamics, Inc.
- Product code
- HRS
- FDA device class
- 2
FDA decision timeline
K261135 received
Application receipt date recorded by FDA.
K261135 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code HRS
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
HERO Sternal Closure SystemK262939 | Hero Orthopedics, LLC | 510(k) clearance | Nov 2, 2026 | FDA |
| ARTHREX, INC. | 510(k) clearance | Oct 29, 2026 | FDA | |
ANTHEM Fracture SystemK262779 | GLOBUS MEDICAL, INC. | 510(k) clearance | Oct 23, 2026 | FDA |
Tempo Plating SystemK263407 | Pace Surgical | 510(k) clearance | Oct 23, 2026 | FDA |
Park's Pectus SystemK263269 | Tdm Co., Ltd. | 510(k) clearance | Oct 15, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Skeletal Dynamics, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Miami, FL
Sources and methodology
- Original FDA record: K261135
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


